Confidential listing · Kangra, Himachal Pradesh · Full sale
The short answer
An injectable pharma plant for sale in Kangra district, Himachal Pradesh, in the Sansarpur Terrace industrial area. It holds Form 25 and Form 28 licences, first granted in 2008 and retained to February 2028, for eight sections across a general block and a beta-lactam block. The asking price is INR 40 crore for a full sale.
The general block covers tablets, capsules, small volume parenterals (ampoules, vials and dry powder) and eye/ear drops. The beta-lactam block covers tablets, capsules, dry syrup and dry powder injections. Four of the eight sections have been upgraded to the revised Schedule M; the other four are being upgraded now. The site is on land leased from the HP Department of Industries, with about 110,000 sq ft built up and a vacant, already-built block for expansion.
- Asking priceINR 40 Cr
- Licensed sections8 (general + beta-lactam)
- Licensed since2008 · valid to 2028
- Land / built-up~3,740 sq m / ~110,000 sq ft
- CertificationState GMP, GLP, ISO 9001
- Workforce157 employees
Source of the figures. Sections, equipment, utilities, headcount and certificates come from the seller’s Site Master File (effective November 2025), licence and certificate copies, and the owner’s update of September 2026. Land and built-up area were supplied by the seller. Laafon Galaxy has not verified any of them; use this page to plan a site visit and document check.
Which sections are ready today
Select a section to see its equipment. Green sections have been upgraded to the revised Schedule M; amber sections are being upgraded.
Sections upgraded to revised Schedule M4 of 8
UpgradedUpgrade in progress
-
Two granulation lines (60 kg and 120 kg), four compression machines and two auto-coaters. Five packing lines: two Alu-Alu, two blister and one strip.
-
Two semi-automatic capsule filling machines (SA-9 type), with blending, polishing and dedicated capsule filling rooms on the first floor.
-
Three ampoule lines (two eight-head, one four-head) and one four-head vial line, plus a dry powder filling and sealing room. Filling rooms are marked Grade B on the layout drawings.
-
One ophthalmic filling line in a dedicated filling and sealing room within the sterile suite.
-
One 60 kg granulation line with compression and coating rooms, and a blister packing machine for the block.
-
One semi-automatic capsule filling machine (SA-9 type) in a combined filling and polishing room.
-
Three-head bottle filling line, with separate granulation, filling and sealing rooms.
-
A 120 vials/min line with a sterilising and depyrogenation tunnel, per the owner’s September 2026 update (the November 2025 equipment list shows an 80–100 vials/min filler). First-floor sterile suite with Grade B filling and sealing rooms.
Count only the green sections as running capacity. The revised Schedule M deadline for firms with turnover up to INR 250 crore was 31 December 2025 [2], and the Health Ministry signalled it would not extend it further [9]. Value the amber sections as capacity to be commissioned until the State authority has inspected them against the revised standard.
Inside the injectable pharma plant for sale in Kangra
Photographs supplied by the seller from the general and beta-lactam oral solid blocks and the documentation room. Select any image to enlarge it.
-
General OSD: granulation 1Fluid bed dryer, rapid mixer granulator and sifting equipment. -
General OSD: granulation 2Blender, fluid bed dryer, granulator and sifter with dust extraction. -
Beta-lactam block: dry syrup granulationTray dryer, double cone blender and sifter. -
Beta-lactam block: dry syrup fillingPowder filling, capping and induction sealing on one conveyor. -
Documentation room: recordsIndexed archive of controlled records. -
Documentation room: workstationsDocument control desks with printer.
What you are buying
Licences and certificates
- Form 25 and Form 28 manufacturing licences, first granted on 19 February 2008 by the Drugs Licensing Authority, Himachal Pradesh (Dharamshala office) [5]. They were retained on payment of the retention fee for 19 February 2023 to 18 February 2028 [4].
- Endorsed sections. General: tablets, capsules, small volume parenterals (dry and liquid), and ophthalmic preparations including ear drops. Beta-lactam: tablets, capsules, dry syrup and small volume parenterals (dry only).
- State GMP certificate issued June 2025, valid for three years, and a GLP certificate for the QC laboratory under Schedule L-1 of the same date. Both state that they were issued for government tender participation. On the GMP certificate the word “revised” before Schedule M is struck out, so it does not certify compliance with the revised standard.
- WHO-GMP: a WHO-format GMP certificate, based on a 2022 inspection, was held until September 2025. The owner is completing the revised Schedule M upgrade and will then re-apply.
- ISO 9001:2015 certificate valid to December 2026.
Ask at diligence: the product permission list endorsed on each licence, and which beta-lactam classes the beta-lactam block may run. The licence names the category “beta-lactam”, while the WHO-format certificate, the Site Master File and the layout drawings call it “cephalosporin” or “Cepha”. The product list contains both penicillins and cephalosporins, yet the Site Master File answers “None” for sensitising materials and for dedicated or campaign manufacture.
Two production blocks, as drawn
| Block and floor | Declared use |
|---|---|
| General, ground | Raw material stores and dispensing, tablet granulation, four compression rooms, coating, Alu-Alu, blister, strip and pouch packing, finished goods store |
| General, first | Ampoule and vial washing and sterilisation, ampoule, vial and ophthalmic filling, dry powder filling, visual inspection, labelling; capsule blending, filling and polishing |
| Beta-lactam, ground | Tablet granulation, compression, coating and blister packing; capsule filling; dry syrup granulation, filling and sealing; water plant, HVAC plant and air compressors |
| Beta-lactam, first | Dry powder injection washing, filling and sealing; QC laboratory, stability and microbiology; air handling unit room |
| Third block | Built and vacant, available for expansion |
Scroll the table sideways on a phone.
Physical segregation is already built in. General and beta-lactam products sit in separate blocks with their own water loops and air handling units, and the sterile suites carry Grade B, C and D room classifications on the layout drawings.
Reconcile the areas. The seller gives the land as about 3,740 sq m, but the Site Master File states a 6,000 sq m plot. Ask for the lease deed, the approved building plan and a room-wise area statement, and check the land area, the built-up area and the vacant block against them before you price the building.
About 750 entries on the product list
Counted from the product list attached to the Site Master File. Navy bars are general products, brass bars beta-lactam.
- Injectables: analgesics, antibiotics, vitamins and methylcobalamin, anaesthetics, iron, anticoagulants, emergency and critical-care drugs.
- Beta-lactam: amoxicillin and clavulanate, ampicillin and cloxacillin, cefixime, cefpodoxime, cefuroxime, ceftriaxone and ceftazidime combinations, meropenem and piperacillin-tazobactam.
- Ophthalmic: fluoroquinolone and aminoglycoside drops with steroid combinations, glaucoma drops and lubricants.
- Oral solids: a broad generic range covering analgesics, anti-infectives, cardio-diabetic, gastro and vitamin combinations.
Screen the list before you value it. It includes many fixed-dose combinations, veterinary-only and export-only entries, and anabolic steroids. Check each product against the licence endorsement and the current banned-FDC notifications, and value only what is both permitted and actually selling.
Utilities, as declared
- HVAC: 80 air handling units, dedicated by area: 23 general oral solids, 17 general liquid injection, 22 beta-lactam oral solids and dry syrup, 9 dry injection and 9 microbiology. Terminal HEPA filtration, about 10% fresh air, 20–25°C.
- Chilled water: two 160 TR chillers with cooling towers.
- Water: bore-well feed to a purified water plant (RO and mixed bed with UV). A multi-column distillation plant feeds two jacketed 1,000 L WFI tanks, one for each block, each with its own distribution loop and sampling points.
- Steam: wood-fired boiler (600 kg/h, non-IBR, per the equipment list).
- Gases: two air compressors with air dryer, and an oxygen and nitrogen plant.
- Power and effluent: transformer and DG set (500 kVA each per the equipment list) and an on-site ETP.
Quality control
- Instruments: four HPLCs, FTIR, UV-Vis spectrophotometer, two dissolution apparatus, two stability chambers (30°C/65% RH and 40°C/75% RH) and a TOC analyser.
- Microbiology: sterility testing room, microbial limit testing, media preparation, incubators, autoclave and antibiotic zone reader.
- The Site Master File lists five outside laboratories for the few tests not done in-house.
Three things to raise early:
- QC and microbiology sit on the first floor of the beta-lactam block. Ask how samples and staff move between blocks and how the lab, especially sterility testing, is kept free of beta-lactam residue.
- Steam comes from a wood-fired boiler. Confirm the air consent for it and how steam quality is controlled where it reaches autoclaves and the WFI still.
- Documentation is manual. With four HPLCs, a revised Schedule M inspector will look at data integrity, so ask about audit trails and backups.
Revised Schedule M and the licences
The revised Schedule M was notified as G.S.R. 922(E) on 28 December 2023 [1]. Firms with turnover up to INR 250 crore had until 31 December 2025, provided they applied with an upgradation plan [2], and State inspections against the new standard began in November 2025 [3]. The oral solid sections here, including the whole beta-lactam oral block, are already upgraded. The sterile, ophthalmic and general capsule sections are the work still to finish, so a buyer should know exactly where each stands.
| Deal element | What happens |
|---|---|
| Share purchase | The licensee company stays the same and the licences continue. Notify the Licensing Authority of the change in constitution; the licence then stays valid for up to three months unless a fresh licence is taken [6]. You inherit the company’s history, including past liabilities. |
| Asset purchase | The licences stay with the seller. You need a fresh application, inspection and grant against the revised Schedule M, and production stops until they are granted. |
| Leased industrial land | Under HP’s 2019 rules, transfer of leasehold rights needs the Director of Industries’ permission and a share of the unearned increase in premium: 5% of it where the unit has run for five years or more. The change-of-constitution rule is written around the original shareholders keeping at least 51%, so get the Department’s position on a full share sale in writing [7]. |
Scroll the table sideways on a phone.
To compare against building a sterile plant from scratch, use the plant setup cost calculator.
Ten questions to put to this seller
- Licence copies with the endorsed product permission lists, and which beta-lactam classes are permitted.
- For each section: the revised Schedule M gap assessment, whether an extension application was filed, the latest State inspection report, and whether it is producing today.
- The plan and timeline for re-applying for WHO-GMP.
- The lease deed, its remaining term, dues paid, and the Department of Industries’ position on the transfer.
- The approved building plan and a room-wise area statement covering all three blocks.
- Three years of audited accounts, split between own brands, third-party manufacturing and tender supplies.
- Media fill records for the ampoule, vial and dry powder lines, sterilisation validation and cleanroom qualification.
- How penicillin and cephalosporin products are separated in the beta-lactam block: campaigning, cleaning validation and residue test methods [8].
- PW and WFI validation, Pollution Control Board consents (air and water), and boiler records.
- HPLC audit trails and data backup, and which key technical staff will stay on.
For everything else, use our 50-point pharma plant acquisition checklist.
Deal terms and ideal buyer
This injectable pharma plant for sale in Kangra is offered as a full sale of the company with its leasehold land, buildings, machinery, utilities, licences, product permissions and documentation. The asking price is INR 40 crore. Financials, licence copies and technical files are shared only after a mutual NDA.
Who it suits: a company that needs ampoules, vials and eye drops under one licence alongside oral solids; a group adding a separate beta-lactam block without building one; a tender supplier that already works with State GMP and GLP certificates; or a CDMO that can finish the sterile upgrade and use the vacant block to grow.
Register interest in this Kangra unit
In your first message, send your company name, business model and how you plan to use the plant. Put Injectable Pharma Plant for Sale in Kangra in the subject line.
Darshan Singh · Promoter representative
Email: contact@laafon.com
Phone / WhatsApp: 9812446733
Frequently asked questions
Its licences cover eight sections. General: tablets, capsules, small volume parenterals (ampoules, vials and dry powder) and eye/ear drops. Beta-lactam: tablets, capsules, dry syrup and dry powder injections.
General tablets and the beta-lactam tablets, capsules and dry syrup sections have been upgraded. General capsules, the sterile injectable sections and eye/ear drops are being upgraded. Confirm each with the latest State inspection report.
It held a WHO-format GMP certificate until September 2025. It now holds a State GMP certificate and a GLP certificate issued in June 2025, and the owner will re-apply for WHO-GMP after the upgrade.
No. The land is leased from the Himachal Pradesh Department of Industries. Transfer of leasehold rights needs the Department’s permission and a transfer charge under the State’s industrial rules.
In a share purchase, the licensee company stays the same and the Form 25 and Form 28 licences continue once the Licensing Authority has been told of the change in constitution. In an asset purchase they do not transfer, and fresh licences are needed.
The asking price is INR 40 crore for a full sale of the company. Licence copies, financials and technical files are released through a data room after a mutual NDA, and then a site visit is arranged. Bring a sterile-manufacturing quality professional to the visit.
References
- Ministry of Health and Family Welfare. Drugs (Amendment) Rules, 2023 (revised Schedule M). G.S.R. 922(E), 28 December 2023. Notified text (PDF). Accessed September 2026.
- Ministry of Health and Family Welfare. Drugs (Amendment) Rules, 2025: revised Schedule M deadline extended to 31 December 2025 for manufacturers with turnover up to INR 250 crore that applied with an upgradation plan. G.S.R. 127(E), 11 February 2025. Reported by Business Standard, 24 March 2025. Trade press.
- Business Standard. Pharma units likely to face action for Schedule M violations: experts. 10 November 2025. business-standard.com. Trade press.
- Ministry of Health and Family Welfare. Drugs and Cosmetics (Tenth Amendment) Rules, 2017. G.S.R. 1337(E), 27 October 2017 (licence renewal replaced by a retention fee every five years). Summary on Mondaq. Accessed September 2026.
- Directorate of Health Safety and Regulation, Himachal Pradesh. State Drugs Control Administration. dhsr.hp.gov.in; online licensing at dcla.hp.gov.in. Accessed September 2026.
- Drugs and Cosmetics Rules, 1945. Form 25 (Rule 70) and Form 28 (Rule 76): licence conditions on change in the constitution of the firm. Specimen licence text (PDF). Accessed September 2026.
- Government of Himachal Pradesh, Department of Industries. Himachal Pradesh Industrial Investment Policy, 2019 and Rules for Grant of Incentives, Concessions and Facilities, 2019, Rules 6.10 and 6.11. Notification No. Ind.-A(F)2-2/2019-I, 16 August 2019. Notified text (PDF). Check for later amendments.
- US Food and Drug Administration. Non-Penicillin Beta-Lactam Drugs: A CGMP Framework for Preventing Cross-Contamination. Guidance for Industry. fda.gov (PDF). International benchmark, not Indian law.
- Business Standard. Health ministry unlikely to extend Schedule M GMP deadline for MSME pharma. 29 December 2025. business-standard.com. Trade press.
This listing is commercial and technical information for prospective buyers. It is not investment, legal or tax advice, and it is not an offer. All figures are declared by the seller and have not been independently verified by Laafon Galaxy Pharmaceuticals. Check them against original documents and a physical inspection, and confirm the current regulatory position with the Drugs Control Administration, Himachal Pradesh, the Department of Industries and your own advisers before committing funds.
